- Australia’s CSL delays spin-off as US flu vaccine rates decline Reuters
- CSL And WiseTech Stumble, Dragging Australia’s Market Down Finimize
- ASX 200 Update: Stocks Move Amid Earnings and Takeover Buzz Kalkine Media
- CSL bloodbath: Investors lose $15 billion in minutes The Nightly
- CSL says no longer targeting completion of demerger in FY2026 MarketScreener